Inhibition of lipopolysaccharide-induced I-κB degradation and tumor necrosis factor-α expression by acriflavine, an antimicrobial agent
- 1 October 2000
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 22 (10) , 775-787
- https://doi.org/10.1016/s0192-0561(00)00039-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Regulators of G-Protein Signaling (RGS) 1 and 16 Are Induced in Response to Bacterial Lipopolysaccharide and Stimulate c-fos Promoter ExpressionBiochemical and Biophysical Research Communications, 1999
- Complementation Cloning of NEMO, a Component of the IκB Kinase Complex Essential for NF-κB ActivationCell, 1998
- Pharmacokinetics, tissue distribution and metabolism of acriflavine and proflavine in the channel catfish (Ictalurus punctatus)Xenobiotica, 1998
- Bacterial Lipopolysaccharide Induces Early and Late Activation of Protein Kinase C in Inflammatory Macrophages by Selective Activation of PKC-ϵBiochemical and Biophysical Research Communications, 1997
- Enhanced Anti-tumour Effects of Acriflavine in Combination with Guanosine in MiceJournal of Pharmacy and Pharmacology, 1997
- Antioxidants differentially affect nuclear factor κB‐mediated nitric oxide synthase expression in vascular smooth muscle cellsFEBS Letters, 1996
- Prevention of Lipopolysaccharide-Induced Lethal Toxicity by Tyrosine Kinase InhibitorsScience, 1994
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Diseases of aquarium fish--4: treatmentPublished by Wiley ,1977
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970